1. Home
  2. PRTA vs ACIC Comparison

PRTA vs ACIC Comparison

Compare PRTA & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • ACIC
  • Stock Information
  • Founded
  • PRTA 2012
  • ACIC 1999
  • Country
  • PRTA Ireland
  • ACIC United States
  • Employees
  • PRTA N/A
  • ACIC N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • ACIC Property-Casualty Insurers
  • Sector
  • PRTA Health Care
  • ACIC Finance
  • Exchange
  • PRTA Nasdaq
  • ACIC Nasdaq
  • Market Cap
  • PRTA 643.0M
  • ACIC 632.9M
  • IPO Year
  • PRTA N/A
  • ACIC N/A
  • Fundamental
  • Price
  • PRTA $13.77
  • ACIC $12.12
  • Analyst Decision
  • PRTA Buy
  • ACIC Buy
  • Analyst Count
  • PRTA 7
  • ACIC 1
  • Target Price
  • PRTA $46.50
  • ACIC $16.00
  • AVG Volume (30 Days)
  • PRTA 711.1K
  • ACIC 189.6K
  • Earning Date
  • PRTA 02-13-2025
  • ACIC 02-27-2025
  • Dividend Yield
  • PRTA N/A
  • ACIC 4.13%
  • EPS Growth
  • PRTA N/A
  • ACIC N/A
  • EPS
  • PRTA N/A
  • ACIC 1.76
  • Revenue
  • PRTA $133,350,000.00
  • ACIC $290,784,000.00
  • Revenue This Year
  • PRTA $56.89
  • ACIC N/A
  • Revenue Next Year
  • PRTA N/A
  • ACIC $12.68
  • P/E Ratio
  • PRTA N/A
  • ACIC $6.91
  • Revenue Growth
  • PRTA N/A
  • ACIC 1.02
  • 52 Week Low
  • PRTA $11.70
  • ACIC $8.82
  • 52 Week High
  • PRTA $34.75
  • ACIC $15.08
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 48.19
  • ACIC 40.29
  • Support Level
  • PRTA $12.39
  • ACIC $11.98
  • Resistance Level
  • PRTA $13.64
  • ACIC $12.87
  • Average True Range (ATR)
  • PRTA 1.03
  • ACIC 0.48
  • MACD
  • PRTA -0.02
  • ACIC -0.07
  • Stochastic Oscillator
  • PRTA 40.47
  • ACIC 24.20

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About ACIC American Coastal Insurance Corporation

American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary. The company has two segments namely: Commercial Lines Business and Personal Lines Business. It derives maximum revenue from Commercial Lines Business Segment.

Share on Social Networks: